查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010002

医疗设备市场：2026-2032年全球市场预测（依产品、技术、用途、应用、最终用户及通路划分）

Medical Devices Market by Product, Technology, Mode of Use, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年医疗设备市场价值为4,029.2亿美元，预计到2026年将成长至4,267.4亿美元，复合年增长率为6.22%，到2032年将达到6,149.1亿美元。

主要市场统计数据
基准年 2025 4029.2亿美元
预计年份：2026年 4267.4亿美元
预测年份 2032 6149.1亿美元
复合年增长率 (%) 6.22%

在瞬息万变的医疗设备市场环境中，需要一个简洁的策略重点和分析范围架构来引导高阶主管决策。

医疗设备业正经历一场策略转型，其驱动力来自于技术、法规和医疗服务模式的融合。本导言明确阐述了执行摘要的目的：整合关键市场动态，识别正在重塑产品生命週期和商业化策略的结构性变化，并为领导者提供切实可行的应对路线图。因此，后续分析将以决策为导向，强调实际应用和商业性影响，而非抽象的趋势分析。

对不断变化的贸易环境中不断上升的关税压力如何重新评估采购、合约设计和产品设计中的优先事项，以及如何保护市场准入和利润率进行实际分析。

针对医疗设备零件和成品的关税上调，对整个生态系统的采购惯例、成本结构和策略规划产生了累积影响。进口关税的调整迫使製造商重新评估其供应商布局，权衡低成本地区与远端供应链营运风险之间的利弊。因此，各组织越来越重视双重采购、近岸外包和增加库存缓衝，以保护生产免受成本剧烈波动和贸易政策变化的影响。

透过对产品类型、底层技术、使用模式、临床应用、最终用户和分销管道的全面细分洞察，得出可操作的策略重点。

深入的市场細項分析揭示了竞争格局、进入障碍和成长机会如何在产品类别、技术模式、使用模式、临床应用、终端用户和通路之间相互交织。产品细分包括穿戴式诊断设备，例如心电图仪、血糖仪和智慧型手錶；影像设备，涵盖CT、MRI、PET扫描仪、超音波和X射线；以及体外诊断试剂，涵盖临床化学、血液学、免疫检测、微生物学和分子诊断，所有这些都与医疗植入并存，从心血管和牙科植入到神经刺激设备和整形外科植入。监测设备包括血压计、心电图仪、胎儿分娩监视器监视器、血糖仪和综合病患监测系统，而外科手术设备包括电外科器械、内视镜器械、一般外科器械、机器人手术系统、手术缝合器、缝线和网片。治疗设备涵盖整个市场，产品类别包括去心房颤动、透析机、电疗设备、输液帮浦、放射治疗设备和呼吸治疗设备。

美洲、欧洲、中东、非洲和亚太地区的区域趋势和市场准入要求决定了准入、部署和营运策略。

区域趋势正在塑造美洲、欧洲、中东、非洲和亚太地区的需求模式、监管预期和供应链结构，每个地区都需要不同的市场进入模式。在美洲，采购流程的日益完善和大规模医疗保健系统的整合，为那些能够提供强有力的临床证据、服务规模以及与电子健康记录整合的供应商创造了机会。在该地区的部分地区，政策制定者和支付者越来越重视基于结果的采购，这迫使製造商提供长期绩效数据以及关于总拥有成本 (TCO) 的论点。

竞争策略趋势表明，市场领导正在整合产品、服务和数据策略，以加速产品普及并确保永续差异化。

医疗设备产业的主要企业正透过整合产品创新、服务和数据驱动成果的综合价值提案来脱颖而出。领导企业的策略重点包括：投资于能够将器械价值延伸至临床环境之外的数位化生态系统；垂直整合製造和供应链功能以控製成本和品质；以及建立策略伙伴关係关係，在共用研发风险的同时加快产品上市速度。那些能够将临床证据的累积与报销策略和医疗保健系统优先事项相契合的企业，在产品推广速度和相关人员信心方面始终优于同行。

为建立具有韧性的供应链、以证据主导的商业化以及「软体优先」的产品蓝图提供切实可行的策略建议，从而增强竞争优势。

致力于将颠覆性创新转化为竞争优势的产业领导者，应整合一系列策略重点，以增强韧性、临床有效性和商业性敏捷性。首先，他们应调整研发蓝图的方向，优先发展模组化平台和软体，利用上市后数据持续改善产品，同时加速产品上市速度。在製定产品策略的同时，他们还应透过以下方式增强供应链韧性：供应商多元化；根据前置作业时间和监管要求，在适当情况下开发近岸製造方案；以及实施先进的库存分析，以平衡服务水准和资本效率。

为了确保获得切实检验的见解，我们采用了一种稳健的混合调查方法，该方法结合了实地访谈、监管分析、供应链映射和证据三角检验。

本研究途径将与负责人进行的定性研究与同行评审文献、监管文件和公共文件的二次分析相结合，以确保研究结果既有实际情况支撑，也有既定趋势佐证。主要研究包括对临床医生、采购经理、监管专家、製造企业高管和技术整合商进行结构化访谈，以收集关于推广障碍、临床效用和营运限制的不同观点。这些访谈辅以实地观察和案例研究，以检验产品在真实医疗环境中的表现，并识别工作流程整合的挑战。

将颠覆性因素转化为永续的竞争优势，透过简洁地整合策略挑战，使产品创新、供应链韧性和证据生成保持一致。

总之，医疗设备业正受到技术融合、监管预期变化和地缘政治影响的重塑，所有这些因素共同要求企业采取更整合和灵活的应对措施。能够将敏捷的产品策略与稳健的供应链相结合、将循证实践融入商业化计划、并采用能够透过服务和数据驱动的交付方式在初始销售之外创造价值的经营模式的企业，将获得成功。区域差异至关重要。根据当地需求调整市场进入策略和伙伴关係关係，对于应对不同的监管和采购环境仍然至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗设备市场：依产品划分

  • 诊断设备
    • 诊断穿戴式装置
      • 心电图监测仪
      • 血糖监测仪
      • 智慧型手錶
    • 医疗影像设备
      • 电脑断层扫描（CT）
      • 磁振造影（MRI）
      • PET扫描仪
      • 超音波
      • X射线
    • 体外诊断医疗设备（IVD）
      • 临床化学
      • 血液学
      • 免疫检测
      • 微生物学
      • 分子诊断
  • 医疗植入
    • 心血管植入
    • 人工植牙
    • 神经刺激设备
    • 整形外科植入
  • 监控设备
    • 血压监测仪
    • 心臟监测设备
    • 胎儿分娩监视器
    • 血糖监测仪
    • 病患监测系统
  • 手术器械
    • 电外科设备
    • 内视镜设备
    • 一般外科器械
    • 机器人手术系统
    • 手术缝合器
    • 缝合线和网片
  • 治疗设备
    • 去心房颤动
    • 透析机
    • 电疗设备
    • 点滴帮浦
    • 放射治疗设备
    • 呼吸治疗设备

第九章：医疗设备市场：依技术划分

  • 3D列印医疗设备
  • 人工智慧设备
  • 数位连网型设备
  • 使用雷射技术的设备
  • 利用奈米技术的设备
  • 机器人设备
  • 传统非数位设备

第十章：以使用模式分類的医疗设备市场

  • 可重复使用的医疗设备
  • 一次性/用完即弃医疗设备

第十一章：医疗设备市场：依应用领域划分

  • 循环系统
  • 牙科
  • 皮肤科
  • 耳鼻喉科
  • 胃肠病学
  • 一般外科
  • 妇科
  • 神经病学
  • 肿瘤学
  • 眼科
  • 整形外科
  • 呼吸系统医疗设备
  • 泌尿系统

第十二章医疗设备市场：依最终用户划分

  • 学术和研究机构
  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 居家医疗
  • 医院
  • 长期照护机构

第十三章：医疗设备市场：依分销管道划分

  • 离线
    • 向医疗机构销售
    • 店面销售
  • 在线的
    • 企业网站
    • 电子商务平台

第十四章医疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国医疗设备市场

第十八章：中国医疗设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • Agappe Diagnostics Ltd.
  • Alcon Inc.
  • Align Technology, Inc.
  • AliveCor, Inc.
  • AptarGroup, Inc.
  • ARKRAY, Inc.
  • B. Braun Melsungen SE
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • BioSerenity Medical Devices Group
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • CMR Surgical Ltd.
  • Edwards Lifesciences Corporation
  • Eko Health Inc.
  • Fresenius Medical Care AG
  • FUJIFILM Healthcare Americas Corporation
  • GE Healthcare Technologies Inc.
  • Healthy.io Ltd
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Masimo Corporation
  • Medtronic plc
  • Olympus Corporation
  • ResMed Inc.
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Sonova Holding AG
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-434CCDA04CB4

The Medical Devices Market was valued at USD 402.92 billion in 2025 and is projected to grow to USD 426.74 billion in 2026, with a CAGR of 6.22%, reaching USD 614.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 402.92 billion
Estimated Year [2026] USD 426.74 billion
Forecast Year [2032] USD 614.91 billion
CAGR (%) 6.22%

Concise framing of strategic priorities and analytical scope to orient executive decision-makers in a rapidly evolving medical devices market environment

The medical devices landscape is undergoing a period of strategic transition driven by converging forces in technology, regulation, and care delivery models. This introduction frames the purpose of the executive summary: to synthesize critical market dynamics, identify structural shifts reshaping product lifecycles and commercialization strategies, and surface practical paths for leaders to respond. It positions the subsequent analysis to be decision-focused, emphasizing operational levers and commercial implications rather than abstract trend-watching.

Readers can expect a coordinated narrative that links product innovation, evolving procurement practices, and supplier economics to clinician adoption and patient outcomes. The introduction emphasizes the importance of cross-functional alignment-engineering, regulatory, commercial, and supply chain teams must act in concert to realize both short-term resilience and long-term competitive advantage. Finally, this opening underscores that actionable intelligence depends on combining qualitative insights from field experts with rigorous secondary synthesis, ensuring recommendations are both pragmatic and strategically ambitious.

A series of transformative shifts is reconfiguring how devices are designed, produced, and delivered, with implications that extend from R&D investment to point-of-care utilization. First, digitalization and AI integration are moving beyond proofs of concept into embedded clinical workflows; devices that combine sensing, analytics, and interoperable data streams are increasingly valued for their ability to demonstrate clinical and operational outcomes. Second, manufacturing paradigms are shifting as additive manufacturing and modular assembly enable localized production, faster iteration cycles, and more patient-specific therapies, which in turn challenge traditional supplier relationships.

Simultaneously, regulatory frameworks and reimbursement models are adapting to value-based care expectations, requiring manufacturers to document longitudinal outcomes and real-world performance. This is prompting closer collaboration between manufacturers and health systems around data collection, post-market surveillance, and evidence generation. Additionally, sustainability considerations and single-use device waste management are rising in prominence, influencing procurement decisions and R&D priorities. Together, these forces are creating a market that rewards integrated solutions, adaptable supply chains, and demonstrable health economic value.

Practical analysis of how elevated tariff pressure reshapes sourcing, contract design, and product design priorities to protect access and margins under changing trade conditions

The introduction of elevated tariff activity affecting medical device components and finished goods has had a cumulative impact on sourcing practices, cost structures, and strategic planning across the ecosystem. Import duty adjustments drive manufacturers to reassess supplier footprints, balancing the trade-offs between low-cost geographies and the operational risks of distant supply chains. As a result, organizations increasingly prioritize dual-sourcing, nearshoring, and increased inventory buffers to insulate production from abrupt cost shifts and trade policy volatility.

Procurement teams have responded by redesigning contracts to include more flexible price escalation clauses and longer-term partnerships that share risk across the value chain. Clinical procurement groups and purchasing consortia are re-evaluating total landed cost rather than unit price alone, taking into account logistics, compliance, and time-to-market. These adaptations have accelerated consideration of onshore manufacturing for select product lines where regulatory complexity, lead-time sensitivity, or customer expectations for rapid iteration justify the investment. At the same time, suppliers with diversified geographical footprints and vertically integrated capabilities are better positioned to mitigate tariff-driven disruption and retain buyer confidence.

Finally, the tariff environment has sharpened focus on product design for cost efficiency: engineers and product managers are prioritizing material substitutions, component standardization, and simplified assembly to reduce exposure to import cost variability, while regulatory teams map these design changes to revised validation and submission pathways. Together, these responses form a pragmatic, multi-dimensional approach to preserving market access and protecting margins under shifting trade conditions.

Comprehensive segmentation insight that links product categories, enabling technologies, usage models, clinical applications, end users, and distribution channels into actionable strategic priorities

Insightful segmentation analysis reveals where competitive dynamics, adoption barriers, and growth opportunities intersect across product classes, technology modalities, usage patterns, clinical applications, end users, and distribution routes. Within product segmentation, diagnostic devices including diagnostic wearables such as ECG monitors, glucose monitors and smartwatches; imaging devices spanning computed tomography, magnetic resonance imaging, PET scanners, ultrasound and X-ray; and in vitro diagnostics covering clinical chemistry, hematology, immunoassay, microbiology and molecular diagnostics coexist with medical implants that range from cardiovascular and dental implants to neurostimulators and orthopedic implants. Monitoring devices encompass blood pressure monitors, cardiac monitoring devices, fetal monitors, glucose monitors and comprehensive patient monitoring systems, while surgical devices include electrosurgical and endoscopic instruments, general surgical tools, robotic surgery systems, surgical staplers and sutures and mesh. Therapeutic devices complete the landscape with offerings such as defibrillators, dialysis equipment, electrotherapy devices, infusion pumps, radiotherapy equipment and respiratory therapy devices.

When technology segmentation is layered over product categories, 3D-printed devices, AI-enabled solutions, digital and connected devices, laser-based platforms, nanotechnology-based therapies, robotic systems and traditional non-digital devices each follow distinct adoption arcs driven by clinical utility, regulatory pathways, and manufacturing complexity. Mode-of-use segmentation clarifies lifecycle and procurement implications: reusable devices require sterilization infrastructures and long-term service models, whereas single-use or disposable devices prioritize supply reliability and waste management. Clinical application segmentation from cardiology to urology reveals uneven demand drivers and regulatory scrutiny that affect evidence requirements and commercialization timelines. End users such as academic and research institutes, ambulatory surgical centers, clinics, diagnostic centers, home healthcare providers, hospitals and long-term care facilities each impose unique purchasing processes, service expectations, and product performance thresholds. Finally, distribution channel segmentation highlights the coexistence of offline institutional sales and over-the-counter channels with online company websites and ecommerce platforms, each demanding different commercial capabilities and post-sale support models. Understanding how these segments interact is essential for prioritizing R&D investment, tailoring go-to-market approaches, and optimizing lifecycle management strategies.

Regional dynamics and market engagement imperatives across the Americas, Europe Middle East and Africa, and Asia-Pacific that determine access, adoption, and operational strategy

Regional dynamics are shaping demand patterns, regulatory expectations, and supply chain architectures in distinct ways across the Americas, Europe Middle East and Africa, and Asia-Pacific, each requiring differentiated market engagement models. In the Americas, procurement sophistication and consolidation among large healthcare systems create opportunities for suppliers that can demonstrate robust clinical evidence, scale of service, and integration with electronic health records. Policymakers and payers in parts of the region increasingly favor outcomes-based procurement, which pressures manufacturers to present longitudinal performance data and total cost of care arguments.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and regional certification pathways coexist with divergent reimbursement regimes and infrastructure variability. Manufacturers targeting these markets must balance centralized European regulatory strategies with country-specific commercialization plans, particularly in regions where access depends on local clinical validation and tailored pricing models. The Middle East and Africa present high-growth pockets alongside logistical and regulatory complexity, so partnerships with regional distributors and local clinical champions are frequently decisive.

Asia-Pacific presents a mosaic of innovation hubs, manufacturing centers, and rapidly modernizing health systems. Several markets in the region combine strong local manufacturing capacity with aggressive adoption of digital health platforms, creating both competition and collaboration opportunities for international players. Supply chain proximity and cost advantages can favor manufacturers that optimize regional production, yet success also requires sensitivity to local clinical practice patterns, procurement rules, and regulatory timelines. Across all regions, a common theme is the need for flexible commercial models that accommodate heterogeneous payer structures and varying levels of clinical infrastructure.

Competitive playbook trends revealing how market leaders leverage integrated product, service, and data strategies to accelerate adoption and secure durable differentiation

Leading companies in the medical devices sector are differentiating through integrated value propositions that combine product innovation, services, and data-driven outcomes. Strategic priorities observed among competitive leaders include investment in digital ecosystems that extend device value beyond the point of care, vertical integration of manufacturing and supply chain capabilities to control cost and quality, and strategic partnerships that accelerate route-to-market while sharing development risk. Firms that align clinical evidence generation with reimbursement strategy and health system priorities consistently outperform peers in adoption velocity and stakeholder trust.

Innovation portfolios are being reshaped to emphasize platform-based approaches that allow incremental feature rollouts and software-enabled improvements, thereby extending product lifecycles and creating recurring revenue opportunities through services and analytics. Mergers, acquisitions, and strategic alliances remain tools to fill capability gaps-particularly in software, AI, and localized manufacturing-while enabling faster access to specialized clinical channels. Additionally, companies that excel at post-market surveillance and real-world evidence collection secure competitive advantage by informing iterative improvements and meeting increasingly stringent regulatory expectations. Finally, talent strategies that blend clinical expertise, regulatory know-how, data science, and supply chain experience are central to executing complex cross-functional initiatives and sustaining competitive differentiation.

Practical strategic recommendations to build resilient supply chains, evidence-driven commercialization, and software-first product roadmaps that strengthen competitive advantage

Industry leaders seeking to convert disruption into advantage should adopt a coordinated set of strategic priorities that reinforce resilience, clinical relevance, and commercial agility. Begin by reorienting R&D roadmaps to prioritize modular platforms and software-enabled enhancements that reduce time-to-market while enabling continuous improvement through post-market data. Parallel to product strategy, strengthen supply chain resilience by diversifying supplier bases, developing nearshore manufacturing options where justified by lead-time or regulatory considerations, and implementing advanced inventory analytics to balance service levels with capital efficiency.

Commercial strategies must emphasize evidence generation that aligns with payer requirements and clinician workflows; invest in pragmatic clinical studies and real-world data collection that demonstrate outcomes and cost-effectiveness. Expand service offerings around training, remote monitoring, and predictive maintenance to create recurring revenue and deepen customer relationships. On the organizational front, cultivate cross-functional teams that integrate regulatory, clinical, and commercial expertise early in development to expedite approvals and market uptake. Finally, prioritize cyber and data governance practices to protect patient information and maintain trust as devices become more connected, while exploring sustainability initiatives that address single-use waste and lifecycle environmental impact to meet emerging procurement criteria.

Robust mixed-method research methodology combining field interviews, regulatory analysis, supply chain mapping, and evidence triangulation to ensure practical and validated insights

The research approach synthesizes primary qualitative engagement with practitioners and secondary analysis of peer-reviewed literature, regulatory filings, and public policy documents to ensure findings are grounded in both field realities and documented trends. Primary research involved structured interviews with clinicians, procurement leaders, regulatory experts, manufacturing executives and technology integrators to capture diverse perspectives on adoption barriers, clinical utility, and operational constraints. These interviews were complemented by site-level observations and case reviews to validate how products perform in actual care settings and to identify workflow integration challenges.

Secondary research methods included systematic review of regulatory guidance, standards updates, clinical evidence publications, and technology validation reports to map the evolving compliance landscape and evidence expectations. Supply chain mapping and component sensitivity analysis were used to identify concentration risks and opportunities for nearshoring, while scenario analysis examined the potential operational responses to trade and policy shocks. Data triangulation and cross-validation steps ensured coherence across sources, and findings were peer-reviewed by independent clinical and regulatory advisors to enhance rigor and practical relevance. This mixed-methods approach provides a robust foundation for the strategic recommendations and insights presented.

Concise synthesis of strategic imperatives that align product innovation, supply chain resilience, and evidence generation to convert disruption into sustainable advantage

In conclusion, the medical devices environment is being reshaped by technological convergence, shifting regulatory expectations, and geopolitical influences that together demand a more integrated and adaptive industry response. Companies that succeed will be those that pair agile product strategies with resilient supply chains, embed evidence generation into commercialization plans, and adopt business models that capture value beyond the initial sale through services and data-driven offerings. Regional nuance matters: tailored market entry approaches and partnerships remain essential to navigate diverse regulatory and procurement landscapes.

Operationally, manufacturers should prioritize design choices that reduce exposure to trade and component risks while accelerating digital enablement to demonstrate clinical and economic value. Organizational capabilities must evolve to integrate clinical, regulatory, commercial and engineering perspectives from the earliest stages of development. By aligning strategic investment with pragmatic execution-focused on outcomes, reliability, and customer-centric support-industry participants can convert current disruption into durable advantage and sustained patient impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Devices Market, by Product

  • 8.1. Diagnostic Devices
    • 8.1.1. Diagnostic Wearables
      • 8.1.1.1. ECG Monitors
      • 8.1.1.2. Glucose Monitors
      • 8.1.1.3. Smartwatches
    • 8.1.2. Imaging Devices
      • 8.1.2.1. Computed Tomography (CT)
      • 8.1.2.2. Magnetic Resonance Imaging (MRI)
      • 8.1.2.3. PET Scanners
      • 8.1.2.4. Ultrasound
      • 8.1.2.5. X-ray
    • 8.1.3. In Vitro Diagnostics (IVD)
      • 8.1.3.1. Clinical Chemistry
      • 8.1.3.2. Hematology
      • 8.1.3.3. Immunoassay
      • 8.1.3.4. Microbiology
      • 8.1.3.5. Molecular Diagnostics
  • 8.2. Medical Implants
    • 8.2.1. Cardiovascular Implants
    • 8.2.2. Dental Implants
    • 8.2.3. Neurostimulators
    • 8.2.4. Orthopedic Implants
  • 8.3. Monitoring Devices
    • 8.3.1. Blood Pressure Monitors
    • 8.3.2. Cardiac Monitoring Devices
    • 8.3.3. Fetal Monitors
    • 8.3.4. Glucose Monitors
    • 8.3.5. Patient Monitoring Systems
  • 8.4. Surgical Devices
    • 8.4.1. Electrosurgical Devices
    • 8.4.2. Endoscopic Devices
    • 8.4.3. General Surgical Instruments
    • 8.4.4. Robotic Surgery Systems
    • 8.4.5. Surgical Staplers
    • 8.4.6. Sutures & Mesh
  • 8.5. Therapeutic Devices
    • 8.5.1. Defibrillators
    • 8.5.2. Dialysis Equipment
    • 8.5.3. Electrotherapy Devices
    • 8.5.4. Infusion Pumps
    • 8.5.5. Radiotherapy Equipment
    • 8.5.6. Respiratory Therapy Devices

9. Medical Devices Market, by Technology

  • 9.1. 3D-Printed Devices
  • 9.2. AI-based Devices
  • 9.3. Digital & Connected Devices
  • 9.4. Laser-Based Devices
  • 9.5. Nanotechnology-based Devices
  • 9.6. Robotic Devices
  • 9.7. Traditional Non-Digital Devices

10. Medical Devices Market, by Mode of Use

  • 10.1. Reusable Medical Devices
  • 10.2. Single-Use / Disposable Medical Devices

11. Medical Devices Market, by Application

  • 11.1. Cardiology
  • 11.2. Dentistry
  • 11.3. Dermatology
  • 11.4. ENT
  • 11.5. Gastroenterology
  • 11.6. General Surgery
  • 11.7. Gynecology
  • 11.8. Neurology
  • 11.9. Oncology
  • 11.10. Ophthalmology
  • 11.11. Orthopedics
  • 11.12. Pulmonology
  • 11.13. Urology

12. Medical Devices Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Clinics
  • 12.4. Diagnostic Centers
  • 12.5. Home Healthcare
  • 12.6. Hospitals
  • 12.7. Long-Term Care Facilities

13. Medical Devices Market, by Distribution Channel

  • 13.1. Offline
    • 13.1.1. Institutional Sales
    • 13.1.2. Over-the-Counter
  • 13.2. Online
    • 13.2.1. Company Website
    • 13.2.2. eCommerce Platforms

14. Medical Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Devices Market

18. China Medical Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Abbott Laboratories
  • 19.7. Agappe Diagnostics Ltd.
  • 19.8. Alcon Inc.
  • 19.9. Align Technology, Inc.
  • 19.10. AliveCor, Inc.
  • 19.11. AptarGroup, Inc.
  • 19.12. ARKRAY, Inc.
  • 19.13. B. Braun Melsungen SE
  • 19.14. Baxter International Inc.
  • 19.15. Becton, Dickinson, and Company
  • 19.16. BioSerenity Medical Devices Group
  • 19.17. Boston Scientific Corporation
  • 19.18. Canon Medical Systems Corporation
  • 19.19. Cardinal Health, Inc.
  • 19.20. CMR Surgical Ltd.
  • 19.21. Edwards Lifesciences Corporation
  • 19.22. Eko Health Inc.
  • 19.23. Fresenius Medical Care AG
  • 19.24. FUJIFILM Healthcare Americas Corporation
  • 19.25. GE Healthcare Technologies Inc.
  • 19.26. Healthy.io Ltd
  • 19.27. Intuitive Surgical, Inc.
  • 19.28. Johnson & Johnson
  • 19.29. Masimo Corporation
  • 19.30. Medtronic plc
  • 19.31. Olympus Corporation
  • 19.32. ResMed Inc.
  • 19.33. Siemens Healthineers AG
  • 19.34. Smith & Nephew plc
  • 19.35. Sonova Holding AG
  • 19.36. Stryker Corporation
  • 19.37. Terumo Corporation
  • 19.38. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MODE OF USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ECG MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ECG MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ECG MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SMARTWATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SMARTWATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SMARTWATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PET SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PET SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PET SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICES MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICES MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICES MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICES MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL DEVICES MARKET SIZE, BY FETAL MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL DEVICES MARKET SIZE, BY FETAL MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL DEVICES MARKET SIZE, BY FETAL MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GENERAL SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SUTURES & MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SUTURES & MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SUTURES & MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIALYSIS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIALYSIS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIALYSIS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ELECTROTHERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ELECTROTHERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ELECTROTHERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL DEVICES MARKET SIZE, BY RADIOTHERAPY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL DEVICES MARKET SIZE, BY RADIOTHERAPY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL DEVICES MARKET SIZE, BY RADIOTHERAPY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL DEVICES MARKET SIZE, BY 3D-PRINTED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL DEVICES MARKET SIZE, BY 3D-PRINTED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL DEVICES MARKET SIZE, BY 3D-PRINTED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL DEVICES MARKET SIZE, BY AI-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL DEVICES MARKET SIZE, BY AI-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL DEVICES MARKET SIZE, BY AI-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIGITAL & CONNECTED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIGITAL & CONNECTED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIGITAL & CONNECTED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL DEVICES MARKET SIZE, BY LASER-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL DEVICES MARKET SIZE, BY LASER-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL DEVICES MARKET SIZE, BY LASER-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NANOTECHNOLOGY-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NANOTECHNOLOGY-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NANOTECHNOLOGY-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ROBOTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ROBOTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ROBOTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL DEVICES MARKET SIZE, BY TRADITIONAL NON-DIGITAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL DEVICES MARKET SIZE, BY TRADITIONAL NON-DIGITAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL DEVICES MARKET SIZE, BY TRADITIONAL NON-DIGITAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL DEVICES MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REUSABLE MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REUSABLE MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REUSABLE MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SINGLE-USE / DISPOSABLE MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SINGLE-USE / DISPOSABLE MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL DEVICES MARKET SIZE, BY SINGLE-USE / DISPOSABLE MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DENTISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL DEVICES MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL DEVICES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL DEVICES MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL DEVICES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL DEVICES MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL DEVICES MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL DEVICES MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL DEVICES MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL DEVICES MARKET SIZE, BY INSTITUTIONAL SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL DEVICES MARKET SIZE, BY INSTITUTIONAL SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ECOMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL MEDICAL DEVICES MARKET SIZE, BY ECOMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 250. AMERICAS MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 251. AMERICAS MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 252. AMERICAS MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. AMERICAS MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 254. AMERICAS MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. AMERICAS MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), 2018-2032 (USD MILLION)
  • TABLE 256. AMERICAS MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 257. AMERICAS MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. AMERICAS MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. AMERICAS MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. AMERICAS MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. AMERICAS MEDICAL DEVICES MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 262. AMERICAS MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. AMERICAS MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. AMERICAS MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. AMERICAS MEDICAL DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 266. AMERICAS MEDICAL DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), 2018-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 274. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 276. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA MEDICAL DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 286. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 288. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), 2018-2032 (USD MILLION)
  • TABLE 290. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 296. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 300. LATIN AMERICA MEDICAL DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY IN VITRO DIAGNOSTICS (IVD), 2018-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY MEDICAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPE MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPE MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC WEARABLES, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPE MEDICAL DEVICES MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)

TA